Product Datasheet
|
|
|
Product Description |
|
Product: |
IgG3, Human Plasma |
Catalog Number: |
HU-IGG3 |
Product Page: |
https://www.mol-innov.com/products/IHUIGG3AP1MG |
Description: |
Like IgG1, IgG3 activates complement and has an affinity for fc receptors; thus IgG1 and IgG3 are the more effective of the IgG subclasses. An IgG3 deficiency is associated with Wiscott-Aldrich disease, systemic lupus erythematosus, juvenile diabetes mellitus, and peridontal infections. IgG anti-viral antibodies are restricted to IgG subclasses 1 and 3, with IgG3 antibodies being the first to appear in response to infection. Prepared from plasma shown to be non reactive for HbsAG, anti-HCV, anti-HBc, and negative for anti-HIV 1 & 2 by FDA approved tests. >95percent pure by SDS-PAGE. |
Recommended Storage: |
SAMPLE |
Minimum Shelf Life: |
399.00 |
Source: |
1.0 mg/ml |
Molecular Weight: |
Proteins |
Extinction Coefficient: |
170,000 |
Antigen: |
-20 C |
Target: |
Frozen liquid |
Target Molecular Weight: |
HUMAN IMMUNOGLOBULINS |
Host: |
1287.25 |
Clonality: |
5 |
Isotype: |
Human plasma |
Clone: |
s |
Applications: |
Dry ice |
Cross-reactivity: |
3 years from delivery |
|
Sample Characteristics |
|
Lot Number: |
HU-IGG3-IHUIGG3AP5MG |
Aliquot: |
1 x Human IgG3 Affinity Purified 5mg |
Concentration: |
420 |
Volume: |
1355 |
Specific activity: |
SodiumAzide |
Titer: |
0.02M Sodium Phosphate; 0.15M NaCl; 0.05% Azide; pH 7.4 |
Buffer: |
SAMPLE |
Form: |
1.0 mg |
Preservative: |
1.0 ml |
|
Optimal experimental conditions and working dilutions must be determined by the end user. Sample concentration and volume are for example purposes only and do not necessarily represent the product that will be received. Please contact us for a current lot-specific product datasheet. |
|
For in vitro laboratory use only |
|
Molecular Innovations, Inc. - 46430 Peary Court, Novi, MI 48377, USA Tel: (888) 557-5055 - Fax: (248) 896-0148 - info@mol-innov.com |